Fathallah, A.M.; Ramadan, A.; Karzoun, B.; Leahy, H.; Dave, N.; Khashan, R.; Allababidi, S.; Saidha, S.; Madani, S.
LPX-TI641, a Tim3/4 Agonist, Induces Long-Term Immune Tolerance in Multiple Sclerosis Models. Pharmaceutics 2025, 17, 1402.
https://doi.org/10.3390/pharmaceutics17111402
AMA Style
Fathallah AM, Ramadan A, Karzoun B, Leahy H, Dave N, Khashan R, Allababidi S, Saidha S, Madani S.
LPX-TI641, a Tim3/4 Agonist, Induces Long-Term Immune Tolerance in Multiple Sclerosis Models. Pharmaceutics. 2025; 17(11):1402.
https://doi.org/10.3390/pharmaceutics17111402
Chicago/Turabian Style
Fathallah, Anas M., Abdulraouf Ramadan, Basel Karzoun, Hannah Leahy, Nimita Dave, Raed Khashan, Saleh Allababidi, Shiv Saidha, and Sarah Madani.
2025. "LPX-TI641, a Tim3/4 Agonist, Induces Long-Term Immune Tolerance in Multiple Sclerosis Models" Pharmaceutics 17, no. 11: 1402.
https://doi.org/10.3390/pharmaceutics17111402
APA Style
Fathallah, A. M., Ramadan, A., Karzoun, B., Leahy, H., Dave, N., Khashan, R., Allababidi, S., Saidha, S., & Madani, S.
(2025). LPX-TI641, a Tim3/4 Agonist, Induces Long-Term Immune Tolerance in Multiple Sclerosis Models. Pharmaceutics, 17(11), 1402.
https://doi.org/10.3390/pharmaceutics17111402